✦ LIBER ✦

rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B

✍ Scribed by L. J. Liu; J. H. Wang; S. C. Du; J. H. Tian; R. F. Yang; L. Wei

Book ID: 108886421
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 223 KB
Volume: 17
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2010.01273.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extended treatment with lamivudine and a

Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

✍ Robert P. Perrillo; Hie-Won Hann; Eugene Schiff; David Mutimer; Bernard Willems; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 309 KB

Renal dysfunction in chronic hepatitis B

Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil

✍ Nghi B. Ha; Nghiem B. Ha; Ruel T. Garcia; Huy N. Trinh; Andrew A. Vu; Huy A. Ngu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Adefovir dipivoxil added to ongoing lami

Adefovir dipivoxil added to ongoing lamivudine therapy in patients with lamivudine-resistant hepatitis B e antigen-negative chronic hepatitis B

✍ T. Vassiliadis; N. Nikolaidis; O. Giouleme; K. Tziomalos; N. Grammatikos; K. Pat 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Resistance surveillance in chronic hepat

Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks

✍ Huiling Yang; Christopher E. Westland; William E. Delaney IV1; Elizabeth J. Heat 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Predominance of pre-S1 mutated hepatitis

Predominance of pre-S1 mutated hepatitis B virus in a patient following treatment with adefovir dipivoxil

✍ Erica Villa; Valentina Boarino; Antonella Grottola; Roberta Gelmini; Nicole G. L 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Mutations associated with the therapeuti

Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis

✍ Kazuyoshi Ohkawa; Tetsuo Takehara; Michio Kato; Aimi Kanada; Matsuo Deguchi; Mas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

## Abstract Factors influencing the therapeutic efficacy of adefovir dipivoxil added to continuing lamivudine have not been elucidated in lamivudine‐resistant patients with type B chronic hepatitis. The viral mutations influencing the efficacy of treatment with adefovir dipivoxil were investigated